世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州のDNAシーケンシング市場予測 2019-2027年

EUROPE DNA SEQUENCING MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
96

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは欧州のDNAシーケンシング市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
In 2018, the Europe DNA sequencing market captured market share of XX% in the global market. By the end of the forecast period of 2019-2027, the market is expected to rise with 17.32% CAGR and contribute a net revenue share of X%. Significant funding and infrastructure for cancer genomics fields in Europe, is helping to drive the adoption of cancer liquid and tissue biopsy diagnostics which majorly employs sequencing techniques.

MARKET INSIGHTS

Europe enjoys significant funding and infrastructure for cancer genomics, which helps to drive the DNA sequencing market adoption in this region. Large-scale government funding, faster processing techniques and huge pharmaceutical industry investment are driving the U.K market. The country is expected to account for the highest revenue share by the end of the forecast period for the European region. Other significant markets in this region include Germany, Spain, France, Netherlands, Switzerland, and Austria. The Hartwig Medical Foundation is the first national DNA data 'sequencing' center in Netherland which caters to personalized cancer care. Switzerland’s first high-throughput DNA sequencing platform, which could well become one of Europe’s largest, has opened its doors on Campus Biotech in Geneva. It is increasingly focused on promoting personalized health care and precision medicine across Switzerland.
The process of selective breeding is known to modify the genetic composition of the plants with time. Thus, the ability of DNA markers to advance the precision and efficiency of conservative plant breeding is boosting the DNA sequencing market in Europe.

COMPETITIVE INSIGHTS

Wafergen Bio-Systems, Inc. (merged with Takara Bio), Pacific Biosciences, Appistry Inc., Asuragen, Inc., BGI, F. Hoffmann-La Roche Ltd., Illumina, Adaptive Biotechnologies, Inc., Roche Diagnostics, Spiral Genetics, Inc., Thermo Fisher Scientific, Inc., Ubiquity Genomics, Inc., Agilent Technologies, Inc., Abbott Laboratories, ZS Genetics, Inc. and Cell Microsystems, Inc. are some of the contending market players in Europe for trading the DNA sequencing services and products.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING USE OF PERSONALIZED MEDICINES
3.2.2. GROWTH IN SEQUENCING SERVICES
3.2.3. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES HOLDS THE LARGEST MARKET SHARE IN TERMS OF END USER
3.2.4. SEQUENCING BY SYNTHESIS IS THE WIDELY USED DNA SEQUENCING TECHNOLOGY
3.2.5. BIOMARKER IS THE MOST POPULAR DNA SEQUENCING APPLICATION
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. GROWING BREEDERS REQUIREMENT FOR THE ANIMALS & PLANTS REPRODUCTION
4.1.2. DEVELOPING TECHNOLOGY AND APPLIED MARKETS
4.1.3. INCREASING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING MARKET
4.1.4. INCREASING PREVALENCE OF CANCER CASES
4.1.5. ENTRY OF NEW MARKET PLAYERS
4.1.6. INCREASING CONFERENCES AND WORKSHOPS RELATED TO DNA SEQUENCING MARKET
4.1.7. CONTINUING DECLINE IN SEQUENCING COSTS
4.1.8. GROWTH IN LIQUID BIOPSY APPLICATIONS
4.1.9. INCREASING PERSONALIZED THERAPIES
4.1.10. SURGE IN GENOME MAPPING PROGRAMS
4.2. MARKET RESTRAINTS
4.2.1. ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
4.2.2. LACK OF SKILLED PROFESSIONALS
4.3. MARKET OPPORTUNITIES
4.3.1. INFLUENCE OF PERSONALIZED MEDICINE & BIOMARKER DISCOVERY
4.3.2. INCREASING GROWTH OF THE Y CHROMOSOME TESTING MARKET
4.3.3. ADVANCEMENT IN NGS (NEXT GENERATION SEQUENCING)
4.4. MARKET CHALLENGES
4.4.1. FRONT AND BACK-END CHALLENGES
4.4.2. LIMITATIONS IN BIOINFORMATICS
4.4.3. SOCIAL AND ETHICAL ISSUES
5. MARKET BY END USER
5.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
5.2. HOSPITALS & CLINICS
5.3. PHARMACEUTICAL
5.4. BIOTECHNOLOGY COMPANIES
5.5. OTHER END-USERS
6. MARKET BY TECHNOLOGY
6.1. SEQUENCING BY SYNTHESIS
6.2. ION SEMICONDUCTOR SEQUENCING
6.3. SEQUENCING BY LIGATION (SBL)
6.4. PYROSEQUENCING
6.5. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
6.6. CHAIN TERMINATION SEQUENCING
6.7. NANOPORE SEQUENCING
6.8. OTHER TECHNOLOGIES
7. MARKET BY APPLICATION
7.1. DIAGNOSTICS
7.2. DRUG DISCOVERY
7.3. BIOMARKER DISCOVERY
7.4. PERSONALIZED MEDICINE
7.5. AGRICULTURE & ANIMAL RESEARCH
7.6. REPRODUCTIVE HEALTH
7.7. FORENSICS
7.8. OTHER APPLICATIONS
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
8.1.3. BARGAINING POWER OF BUYER
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. KEY BUYING CRITERIA
8.4. STRATEGIC CONCLUSIONS
8.5. DNA SEQUENCING TIMELINE
8.6. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. THE UNITED KINGDOM (UK)
9.1.2. FRANCE
9.1.3. GERMANY
9.1.4. SPAIN
9.1.5. ITALY
9.1.6. REST OF EUROPE
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. ABBOTT LABORATORIES.
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.1.4. STRATEGIC INITIATIVES
10.2.2. ADAPTIVE BIOTECHNOLOGIES, INC.
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. SCOT ANALYSIS
10.2.2.3. PRODUCT PORTFOLIO
10.2.3. AGILENT TECHNOLOGIES, INC.
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. SCOT ANALYSIS
10.2.3.3. PRODUCT PORTFOLIO
10.2.4. APPISTRY, INC.
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. SCOT ANALYSIS
10.2.4.3. PRODUCT PORTFOLIO
10.2.5. ASURAGEN, INC.
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. SCOT ANALYSIS
10.2.5.3. PRODUCT PORTFOLIO
10.2.6. BGI
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. SCOT ANALYSIS
10.2.6.3. PRODUCT PORTFOLIO
10.2.7. CELL MICROSYSTEMS, INC.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. SCOT ANALYSIS
10.2.8. F. HOFFMANN-LA ROCHE LTD.
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. SCOT ANALYSIS
10.2.8.4. STRATEGIC INITIATIVES
10.2.9. ILLUMINA
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. SCOT ANALYSIS
10.2.9.3. PRODUCT PORTFOLIO
10.2.10. PACIFIC BIOSCIENCES
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. SCOT ANALYSIS
10.2.10.3. PRODUCT PORTFOLIO
10.2.10.4. STRATEGIC INITIATIVES
10.2.11. ROCHE DIAGNOSTICS
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. SCOT ANALYSIS
10.2.11.3. PRODUCT PORTFOLIO
10.2.12. SPIRAL GENETICS, INC.
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. SCOT ANALYSIS
10.2.12.3. PRODUCT PORTFOLIO
10.2.13. THERMO FISHER SCIENTIFIC, INC.
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. SCOT ANALYSIS
10.2.13.3. PRODUCT PORTFOLIO
10.2.14. UBIQUITY GENOMICS, INC.
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. SCOT ANALYSIS
10.2.14.3. PRODUCT PORTFOLIO
10.2.15. WAFERGEN BIO-SYSTEMS, INC. (MERGED WITH TAKARA BIO)
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. SCOT ANALYSIS
10.2.15.3. PRODUCT PORTFOLIO
10.2.16. ZS GENETICS, INC.
10.2.16.1. COMPANY OVERVIEW
10.2.16.2. PRODUCT PORTFOLIO
10.2.16.3. STRATEGIC INITIATIVES

LIST OF TABLES
TABLE 1 EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
TABLE 2 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2018
TABLE 3 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 4 EUROPE DNA SEQUENCING MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 5 EUROPE RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
TABLE 6 EUROPE HOSPITALS & CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE PHARMACEUTICAL MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE BIOTECHNOLOGY COMPANIES MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE OTHER END-USER 2019-2027 ($ MILLION)
TABLE 10 EUROPE DNA SEQUENCING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 11 SBS PARAMETERS AND DESCRIPTION
TABLE 12 EUROPE SEQUENCING BY SYNTHESIS MARKET 2019-2027 ($ MILLION)
TABLE 13 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 14 EUROPE ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
TABLE 15 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 16 EUROPE SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
TABLE 17 ADVANTAGES AND DISADVANTAGES PYROSEQUENCING
TABLE 18 EUROPE PYROSEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 19 SINGLE MOLECULE REAL-TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 20 EUROPE SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
TABLE 21 EUROPE CHAIN TERMINATION SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 22 EUROPE NANOPORE SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 23 EUROPE OTHER TECHNOLOGIES MARKET 2019-2027 ($ MILLION)
TABLE 24 EUROPE DNA SEQUENCING MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 25 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 26 EUROPE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 27 EUROPE DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 28 EUROPE BIOMARKER DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 29 EUROPE PERSONALIZED MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 30 EUROPE AGRICULTURE & ANIMAL RESEARCH MARKET 2019-2027 ($ MILLION)
TABLE 31 EUROPE REPRODUCTIVE HEALTH MARKET 2019-2027 ($ MILLION)
TABLE 32 EUROPE FORENSICS MARKET 2019-2027 ($ MILLION)
TABLE 33 EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 34 EUROPE DNA SEQUENCING MARKET BY COUNTRY 2019-2027 ($ MILLION)


LIST OF FIGURES
FIGURE 1 EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
FIGURE 2 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3 EUROPE DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE DNA SEQUENCING MARKET BY PHARMACEUTICAL 2019-2027 ($ MILLION)
FIGURE 6 EUROPE DNA SEQUENCING MARKET BY BIOTECHNOLOGY COMPANIES 2019-2027 ($ MILLION)
FIGURE 7 BIOTECHNOLOGICAL TOOLS USED FOR CROP PROTECTION
FIGURE 8 EUROPE DNA SEQUENCING MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 9 EUROPE DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS 2019-2027 ($ MILLION)
FIGURE 10 EUROPE DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
FIGURE 11 EUROPE DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
FIGURE 12 EUROPE DNA SEQUENCING MARKET BY PYROSEQUENCING 2019-2027 ($ MILLION)
FIGURE 13 EUROPE DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
FIGURE 14 EUROPE DNA SEQUENCING MARKET BY CHAIN TERMINATION SEQUENCING 2019-2027 ($ MILLION)
FIGURE 15 EUROPE DNA SEQUENCING MARKET BY NANOPORE SEQUENCING 2019-2027 ($ MILLION)
FIGURE 16 EUROPE DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2019-2027 ($ MILLION)
FIGURE 17 EUROPE DNA SEQUENCING MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE DNA SEQUENCING MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
FIGURE 19 EUROPE DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2019-2027 ($ MILLION)
FIGURE 20 EUROPE DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2019-2027 ($ MILLION)
FIGURE 21 EUROPE DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2019-2027 ($ MILLION)
FIGURE 22 EUROPE DNA SEQUENCING MARKET BY REPRODUCTIVE HEALTH 2019-2027 ($ MILLION)
FIGURE 23 EUROPE DNA SEQUENCING MARKET BY FORENSICS 2019-2027 ($ MILLION)
FIGURE 24 EUROPE DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 25 THE UNITED KINGDOM DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 26 FRANCE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 27 GERMANY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 28 SPAIN DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 29 ITALY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 30 REST OF EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 31 DNA SEQUENCING MARKET SHARE ANALYSIS 2017 (%)

List of Tables

LIST OF TABLES
TABLE 1 EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
TABLE 2 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2018
TABLE 3 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 4 EUROPE DNA SEQUENCING MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 5 EUROPE RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
TABLE 6 EUROPE HOSPITALS & CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE PHARMACEUTICAL MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE BIOTECHNOLOGY COMPANIES MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE OTHER END-USER 2019-2027 ($ MILLION)
TABLE 10 EUROPE DNA SEQUENCING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 11 SBS PARAMETERS AND DESCRIPTION
TABLE 12 EUROPE SEQUENCING BY SYNTHESIS MARKET 2019-2027 ($ MILLION)
TABLE 13 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 14 EUROPE ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
TABLE 15 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 16 EUROPE SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
TABLE 17 ADVANTAGES AND DISADVANTAGES PYROSEQUENCING
TABLE 18 EUROPE PYROSEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 19 SINGLE MOLECULE REAL-TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 20 EUROPE SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
TABLE 21 EUROPE CHAIN TERMINATION SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 22 EUROPE NANOPORE SEQUENCING MARKET 2019-2027 ($ MILLION)
TABLE 23 EUROPE OTHER TECHNOLOGIES MARKET 2019-2027 ($ MILLION)
TABLE 24 EUROPE DNA SEQUENCING MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 25 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 26 EUROPE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 27 EUROPE DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 28 EUROPE BIOMARKER DISCOVERY MARKET 2019-2027 ($ MILLION)
TABLE 29 EUROPE PERSONALIZED MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 30 EUROPE AGRICULTURE & ANIMAL RESEARCH MARKET 2019-2027 ($ MILLION)
TABLE 31 EUROPE REPRODUCTIVE HEALTH MARKET 2019-2027 ($ MILLION)
TABLE 32 EUROPE FORENSICS MARKET 2019-2027 ($ MILLION)
TABLE 33 EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 34 EUROPE DNA SEQUENCING MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

LIST OF FIGURES
FIGURE 1 EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)
FIGURE 2 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3 EUROPE DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE DNA SEQUENCING MARKET BY PHARMACEUTICAL 2019-2027 ($ MILLION)
FIGURE 6 EUROPE DNA SEQUENCING MARKET BY BIOTECHNOLOGY COMPANIES 2019-2027 ($ MILLION)
FIGURE 7 BIOTECHNOLOGICAL TOOLS USED FOR CROP PROTECTION
FIGURE 8 EUROPE DNA SEQUENCING MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 9 EUROPE DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS 2019-2027 ($ MILLION)
FIGURE 10 EUROPE DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)
FIGURE 11 EUROPE DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)
FIGURE 12 EUROPE DNA SEQUENCING MARKET BY PYROSEQUENCING 2019-2027 ($ MILLION)
FIGURE 13 EUROPE DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)
FIGURE 14 EUROPE DNA SEQUENCING MARKET BY CHAIN TERMINATION SEQUENCING 2019-2027 ($ MILLION)
FIGURE 15 EUROPE DNA SEQUENCING MARKET BY NANOPORE SEQUENCING 2019-2027 ($ MILLION)
FIGURE 16 EUROPE DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2019-2027 ($ MILLION)
FIGURE 17 EUROPE DNA SEQUENCING MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE DNA SEQUENCING MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
FIGURE 19 EUROPE DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2019-2027 ($ MILLION)
FIGURE 20 EUROPE DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2019-2027 ($ MILLION)
FIGURE 21 EUROPE DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2019-2027 ($ MILLION)
FIGURE 22 EUROPE DNA SEQUENCING MARKET BY REPRODUCTIVE HEALTH 2019-2027 ($ MILLION)
FIGURE 23 EUROPE DNA SEQUENCING MARKET BY FORENSICS 2019-2027 ($ MILLION)
FIGURE 24 EUROPE DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 25 THE UNITED KINGDOM DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 26 FRANCE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 27 GERMANY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 28 SPAIN DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 29 ITALY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 30 REST OF EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)
FIGURE 31 DNA SEQUENCING MARKET SHARE ANALYSIS 2017 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る